Lataa...
Cardiodynamic Interactions between Two S1P(1) Receptor Modulators in an Experimental Clinical Setting: Different Pharmacokinetic Properties as an Opportunity to Mitigate First-Dose Heart Rate Effects
A decrease in heart rate (HR) is a well-established first-dose effect of sphingosine-1-phosphate subtype 1 receptor (S1P1R) modulators. For compounds with a short half-life (t(1/2)), this can be mitigated by gradual up-titration to therapeutic doses, whereas this is not required for compounds with a...
Tallennettuna:
| Julkaisussa: | Int J Mol Sci |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6651405/ https://ncbi.nlm.nih.gov/pubmed/31266149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20133232 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|